 BOSTON, Nov. 22, 2022 GLOBE NEWSWIRE -- Compass Therapeutics, Inc. Nasdaq: CMPX, a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today announced that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference, which is taking place at the Lotte New York Palace November 29 December 1, 2022. 